Arrow Medicare

Rybelsus 14mg Tablet is a medicine used to lower blood sugar levels in adults with type 2 diabetes mellitus. It helps prevent serious complications of diabetes like kidney damage and blindness. Proper control of diabetes also helps lower your chances of a heart attack or a stroke.

Rybelsus 14mg Tablet belongs to the GLP-1 (glucagon-like peptide) group of diabetes medicines. It works by helping the body produce insulin and reducing appetite. It also helps reduce weight in some people. This medicine should be stored in a refrigerator until you need it but do not freeze it.

Is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes

Is a prescription medicine used along with diet and exercise to improve blood sugar (glucose) in adults with type 2 diabetes.

Signaquin 200 mg (hydroxychloroquine) is used to treat autoimmune conditions, malaria, and some skin conditions. It can also improve glycemic control in people with type 2 diabetes. 

HCQS 200 Tablet is used to treat autoimmune conditions such as rheumatoid arthritis and systemic lupus erythematosus. It slows the disease's progression and relieves pain, swelling, and redness. It is also used in patients with type 2 diabetes mellitus to improve glycemic control.

Metford 500 Tablet is a medicine used to treat type 2 diabetes mellitus. It helps control blood sugar levels and thus prevents serious complications of diabetes. It is also used to treat a menstruation-related disorder known as polycystic ovary syndrome (PCOS) in women.

Forxiga 10mg (dapagliflozin) is primarily used to manage type 2 diabetes by lowering blood sugar levels. It also helps reduce the risk of cardiovascular events in people with type 2 diabetes and heart disease. Additionally, it's used to treat chronic kidney disease and chronic heart failure in adults. 

Jardiance 25mg Tablet is used alone or with other medicines to treat type 2 diabetes mellitus. It helps control the high blood sugar levels seen in diabetes, reducing the chances of serious complications and helping prevent heart disease.

Jardiance 10mg Tablet is used alone or with other medicines to treat type 2 diabetes mellitus. It helps control the high blood sugar levels seen in diabetes, reducing the chances of serious complications and helping prevent heart disease.

Biciphage 1000 Tablet SR is a medicine used to treat type 2 diabetes mellitus. It helps control blood sugar levels and thus prevents serious complications of diabetes. It is also used to treat a menstruation-related disorder known as polycystic ovary syndrome (PCOS) in women.

Biciphage 500 Tablet is a medicine used to treat type 2 diabetes mellitus. It helps control blood sugar levels and thus prevents serious complications of diabetes. It is also used to treat a menstruation-related disorder known as polycystic ovary syndrome (PCOS) in women.

Glycoheal 500 Tablet 20 helps manage type 2 diabetes by boosting your body's response to insulin, reducing sugar production in your liver, and decreasing glucose absorption from your intestines.

Dapasmart 10 Tablet is used for the management and treatment of type 2 diabetes. It contains Dapagliflozin, which works by inhibiting the reabsorption of glucose in the body, resulting in an increase in glucose excretion through urine. The removal of excessive glucose helps to lower down the blood sugar level.

Acarboz 25mg Tablet is used to treat people with type 2 diabetes mellitus. It helps lower blood sugar levels after meals. It belongs to a group of medicines known as alpha-glucosidase inhibitors. This medicine is usually prescribed in combination with other diabetes medications.

Aloja 25 Tablet is used in the treatment of type 2 diabetes, especially in patients whose blood sugar levels are not controlled by diet and exercise alone. Aloja 25 Tablet may be used alone or in combination with other medicines.

Wegovy 0.25 mg is the starting dose for a once-weekly injection used to help your body adjust to the medication and minimize gastrointestinal side effects. It is not the long-term maintenance dose. Wegovy (semaglutide) is an injectable prescription for adults and adolescents aged 12 and older with obesity, or adults who are overweight with a weight-related condition. It is used for long-term weight management with diet and exercise, and is approved for reducing heart-related events in adults with cardiovascular disease and obesity or overweight. The 0.25 mg dose is the initial step in a gradual escalation plan, typically administered once weekly for the first four weeks before increasing. Wegovy is given as a subcutaneous injection once weekly, rotating sites such as the abdomen, thigh, and upper arm. Common side effects include gastrointestinal issues like nausea, diarrhea, and vomiting, while serious side effects requiring immediate medical attention include severe abdominal pain or signs of allergic reaction. Unused pens should be refrigerated. If a dose is missed, take it as soon as possible if the next dose is more than 48 hours away; otherwise, skip it.

Wegovy 1mg FlexTouch is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.
Wegovy 1mg FlexTouch is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Wegovy 1mg FlexTouch is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Wegovy 1mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Wegovy 1mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 1mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 1mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Wegovy 1.7mg FlexTouch is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.
Wegovy 1.7mg FlexTouch is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Wegovy 1.7mg FlexTouch is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Wegovy 1.7mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Wegovy 1.7mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 1.7mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 1.7mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Wegovy 2.4mg FlexTouch is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.
Wegovy 2.4mg FlexTouch is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Wegovy 2.4mg FlexTouch is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Wegovy 2.4mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Wegovy 2.4mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 2.4mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 2.4mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Wegovy 0.5mg FlexTouch is a prescription medicine that belongs to a class called GLP-1 receptor agonists. It works in a way similar to a natural hormone in the body that helps manage hunger, digestion, and blood sugar. It works best when combined with healthy eating habits and regular physical activity.
Wegovy 0.5mg FlexTouch is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Wegovy 0.5mg FlexTouch is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Wegovy 0.5mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Wegovy 0.5mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 0.5mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 0.5mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.